AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas

Conclusions: Our results suggest that AXL signaling contributes to the aggressiveness of DDLPS and PLS, and that AXL is therefore a potential therapeutic target for treatment of these rare, yet devastating tumors.

http://www.biomedcentral.com/1471-2407/15/901

Source: BMC Cancer - November 14, 2015 Category: Cancer & Oncology Authors: Caitlin MayJeannine GarnettXiaoYan MaSharon LandersDavis IngramElizabeth DemiccoGhadah Al SannaaTona VuLixia HanYi ZhangChristine KivlinSvetlana BolshakovAzad KalamJuehui LiuFuguo ZhouDominique BroccoliWei-Lien WangAlexander LazarRaphael PollockDina LevKe Source Type: research